|
Notification of cessation of securities - MEM
|
8 June 2023 at 5:05pm
|
|
Felix considered best method to treat cryopreserved semen
|
6 June 2023 at 8:45am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 April 2023 at 10:25am
|
|
Investor presentation April 2023
|
5 April 2023 at 10:00am
|
|
Japan first commercial sale and first baby born using Felix
|
3 April 2023 at 8:45am
|
|
Experienced fertility expert appointed Operations Director
|
30 March 2023 at 8:40am
|
|
Highly-credentialled exec appointed as Director of BusDev
|
28 February 2023 at 8:40am
|
|
Half Yearly Report and Accounts
|
24 February 2023 at 5:50pm
|
|
KOL testings demonstrate Felix System outperforms DGC
|
7 February 2023 at 9:20am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2023 at 9:20am
|
|
Notification of cessation of securities - MEM
|
17 January 2023 at 8:45am
|
|
Change of Director's Interest Notice correction
|
12 January 2023 at 5:45pm
|
|
Change of Director's Interest Notice correction
|
12 January 2023 at 10:30am
|
|
Change of Director's Interest Notice - AC
|
3 January 2023 at 8:40am
|
|
Change of Director's Interest Notice - AG
|
3 January 2023 at 8:40am
|
|
Notification of cessation of securities - MEM
|
9 December 2022 at 5:50pm
|
|
Change of Director's Interest Notice RC
|
6 December 2022 at 5:59pm
|
|
Notification regarding unquoted securities - MEM
|
6 December 2022 at 5:50pm
|
|
Notification of cessation of securities - MEM
|
30 November 2022 at 12:20pm
|
|
Constitution
|
28 November 2022 at 1:50pm
|
|
Results of Meeting
|
28 November 2022 at 1:40pm
|
|
Chairman and MD address to shareholders
|
28 November 2022 at 10:25am
|
|
Change of Registry Address
|
31 October 2022 at 4:30pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
27 October 2022 at 10:20am
|
|
Notice of Annual General Meeting/Proxy Form
|
25 October 2022 at 2:50pm
|
|
FELIX System commercialisation, regulatory plan and trial
|
24 October 2022 at 8:55am
|
|
Appendix 2A
|
10 October 2022 at 9:05am
|
|
Change in substantial holding AG
|
30 September 2022 at 8:55am
|
|
Change of Director's Interest Notice AG
|
30 September 2022 at 8:50am
|
|
Change in substantial holding AC
|
29 September 2022 at 5:35pm
|
|
Change of Director's Interest Notice AC
|
29 September 2022 at 5:35pm
|
|
Change in substantial holding AC
|
23 September 2022 at 8:35am
|
|
Appendix 2A- Application for Quotation of Securities
|
21 September 2022 at 12:15pm
|
|
Rights Issue Closure and Shortfall Notification
|
19 September 2022 at 7:15pm
|
|
Non-Renounceable Issue
|
5 September 2022 at 4:15pm
|
|
Appendix 3B
|
5 September 2022 at 4:00pm
|
|
Full Year Statutory Accounts
|
31 August 2022 at 6:35pm
|
|
Preliminary Final Report
|
31 August 2022 at 6:10pm
|
|
Appendix 4G and Corporate Governance Statement
|
31 August 2022 at 9:10am
|
|
Rights Issue Prospectus despatched
|
29 August 2022 at 4:05pm
|
|
Application for quotation of securities - MEM
|
25 August 2022 at 8:25am
|
|
Rights Issue offer - Letter to ineligible shareholders
|
18 August 2022 at 4:25pm
|
|
Non-Renounceable Issue
|
18 August 2022 at 4:15pm
|
|
Update - Proposed issue of securities - MEM
|
18 August 2022 at 11:50am
|
|
Proposed issue of securities - MEM
|
17 August 2022 at 9:25am
|
|
Reinstatement to Official Quotation
|
17 August 2022 at 9:25am
|
|
$3.36 capital raising to accelerate FELIX commercialisation
|
17 August 2022 at 9:25am
|
|
Court Orders Granted and update on Proposed Capital Raising
|
11 August 2022 at 10:30am
|
|
Cleansing Statement
|
2 August 2022 at 9:10am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 July 2022 at 12:30pm
|
